COMP <GO>
SIBN vs IRMD // EV/EBITDA & P/E VALUATION
SI-BONE Inc. (NASDAQ) VS. iRadimed Corporation (NASDAQ) • 15-METRIC TALLY: SIBN 3
— IRMD 7
■ METRIC PARITY
LAST: $22.41 (+2.66%) • MKT CAP: $1.00B
valuation
—
LAST: $85.74 (+2.16%) • MKT CAP: $1.10B
valuation
31.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SIBN VS. IRMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SIBN | IRMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.60% | 76.70% | +2.90 | SIBN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.30% | 37.70% | -48.00 | IRMD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 31.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.90% | 1.57% | -2.47 | IRMD | /fcf-yield <GO> |
| Operating Margin | -11.10% | 31.20% | -42.30 | IRMD | /operating-margins <GO> |
| Net Profit Margin | -9.40% | 26.80% | -36.20 | IRMD | /net-margins <GO> |
| Revenue Growth (YoY) | 20.20% | 14.40% | +5.80 | SIBN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.37% | -1.37 | IRMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.73 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | IRMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.6 | 25.6 | +33.01 | SIBN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 41.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.00B | $1.10B | -$92.0M | IRMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SIBN REV | IRMD REV | SIBN GROSS % | IRMD GROSS % | SIBN FCF | IRMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $200.9M | $83.8M | 79.6% | 76.7% | -$9.1M | $17.2M |
| FY 2024 | $167.2M | $73.2M | 79.0% | 76.9% | -$22.9M | $17.6M |
| FY 2023 | $138.9M | $65.6M | — | — | -$18.7M | $13.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SIBN // BETA —
IRMD // BETA —